<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01307865</url>
  </required_header>
  <id_info>
    <org_study_id>EFW-001-SA</org_study_id>
    <nct_id>NCT01307865</nct_id>
  </id_info>
  <brief_title>Volume Restoration of the Aging Midface With Sculptra Aesthetic</brief_title>
  <official_title>Volume Restoration of the Aging Midface With Sculptra Aesthetic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Williams Center Plastic Surgery Specialists</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Williams Center Plastic Surgery Specialists</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effect of Sculptra Aesthetic on the cosmetic&#xD;
      rejuvenation of the midface complex. The investigators plan to both qualitatively determine&#xD;
      the restoration of midface architecture as well as quantitatively document the change in&#xD;
      midface volume by employing three-dimensional (3D) surface imaging which critically analyzes&#xD;
      volumetric tissue changes. Our hypothesis is that patients who receive Sculptra Aesthetic&#xD;
      injections will experience significant improvement in facial midface volume restoration.&#xD;
&#xD;
        -  Measure the midfacial volumetric correction from Sculptra Aesthetic treatment, using&#xD;
           three-dimensional digital surface imaging&#xD;
&#xD;
        -  Determine the mean change from baseline in facial contour via quantitative volumetric&#xD;
           measurements&#xD;
&#xD;
        -  Correlate volumetric correction with clinical improvement as measured by the Facial&#xD;
           Lipoatrophy Panel grading system&#xD;
&#xD;
        -  Correlate the mean volumetric change in midfacial treatment area with the amount of&#xD;
           product used&#xD;
&#xD;
        -  Obtain photographs pre- and post-treatment for the purpose of providing a subject visual&#xD;
           aid during the course of treatment&#xD;
&#xD;
        -  Collect safety data&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in midfacial volume from Sculptra Aesthetic treatment, using three-dimensional digital surface imaging</measure>
    <time_frame>6 mo, 9 mo, 12 mo, 15 mo</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlate volumetric correction with clinical improvement as measured by the Facial Lipoatrophy Panel grading system</measure>
    <time_frame>12 mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlate the mean volumetric change in midfacial volume with the amount of product used</measure>
    <time_frame>12 mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course and duration of volumetric correction from Sculptra Aesthetic treatment</measure>
    <time_frame>6 mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course and duration of volumetric correction from Sculptra Aesthetic treatment</measure>
    <time_frame>9 mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course and duration of volumetric correction from Sculptra Aesthetic treatment</measure>
    <time_frame>12 mo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course and duration of volumetric correction from Sculptra Aesthetic treatment</measure>
    <time_frame>15 mo</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Problem of Aging</condition>
  <arm_group>
    <arm_group_label>Sculptra Aesthetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving Sculptra Aesthetic</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>injectable poly-L-lactic acid</intervention_name>
    <description>Each patient will receive up to 1 vial of Sculptra Aesthetic total to both midface complexes at each of 3 treatment sessions, spaced 6 weeks apart.</description>
    <arm_group_label>Sculptra Aesthetic</arm_group_label>
    <other_name>Sculptra Aesthetic</other_name>
    <other_name>Sculptra</other_name>
    <other_name>Poly-L-lactic acid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 40-60 years old&#xD;
&#xD;
          -  BMI greater than 18.5 and less than 24.9&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 40 years or greater than 60 years&#xD;
&#xD;
          -  Prior surgical or non-surgical treatment to the midface within the past 2 years&#xD;
&#xD;
          -  Interested in seeking other treatments to the midface during the study period&#xD;
&#xD;
          -  Pregnant, lactating, or breast feeding&#xD;
&#xD;
          -  Hypersensitivity to poly-L-lactic acid, carboxymethylcellulose, or mannitol&#xD;
&#xD;
          -  Allergy to lidocaine or epinephrine&#xD;
&#xD;
          -  History of atopy, anaphylaxis, or multiple severe allergies&#xD;
&#xD;
          -  Current immunotherapy or history of autoimmune disease&#xD;
&#xD;
          -  History of or active stroke or myocardial infarction&#xD;
&#xD;
          -  History of or active connective tissue disease&#xD;
&#xD;
          -  History of or active bleeding disorders&#xD;
&#xD;
          -  History of or active cancer&#xD;
&#xD;
          -  Serious abnormalities in laboratory findings&#xD;
&#xD;
          -  Active hepatitis&#xD;
&#xD;
          -  Active infection or inflammatory process of skin&#xD;
&#xD;
          -  History of or risk factors for hypertrophic scarring or keloid formation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edwin F Williams, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Williams Center Plastic Surgery Specialists</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Williams Center Plastic Surgery Specialists</name>
      <address>
        <city>Latham</city>
        <state>New York</state>
        <zip>12110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <study_first_submitted>March 2, 2011</study_first_submitted>
  <study_first_submitted_qc>March 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2011</study_first_posted>
  <last_update_submitted>October 13, 2013</last_update_submitted>
  <last_update_submitted_qc>October 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Williams Center Plastic Surgery Specialists</investigator_affiliation>
    <investigator_full_name>Edwin F. Williams, III, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>midface volume loss</keyword>
  <keyword>aging of midface</keyword>
  <keyword>sculptra</keyword>
  <keyword>sculptra aesthetic</keyword>
  <keyword>poly-L-lactic acid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 2, 2016</submitted>
    <returned>February 29, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

